Is CMO up or down today?
CMO is down 0.19% today, last at 115.11. This stock moved -0.19% versus the prior close.
CMO · CMO
CMO (CMO) is trading at 115.11, down 0.19% on the session. CMO sits at the 50% mark of its 52-week range, carries a 14-day RSI of 42, and trades below its 50-day average. Over the past month it is down 3.66%.
Leading the coverage: “Stoke Therapeutics CMO Barry Ticho Executes 5,545 Share Sales Under 10b5-1 Plan - Kalkine Media” (Google News Company, 5d ago). CMO is +2.50% since story.
CMO trades on a trailing P/E of 32.0 and is running 2.72% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
CMO is down 0.19% today, last at 115.11. This stock moved -0.19% versus the prior close.
Leading the coverage: “Stoke Therapeutics CMO Barry Ticho Executes 5,545 Share Sales Under 10b5-1 Plan - Kalkine Media” (Google News Company, 5d ago). CMO is +2.50% since story. Dominant story: Maze therapeutics president, R&D & CMO, sells $254,501 in shares By Investing.com - Investing.com India (1 source, neutral) RSI is 42 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (181 days) · Drag or scroll left for earlier dates
Maze therapeutics president, R&D & CMO, sells $254,501 in shares By Investing.com - Investing.com India
Tectonic Therapeutic (TECX) grants 24,250 options to its CMO - Stock Titan
Nayax (NYAX) CMO's 34-share sale covers taxes - Stock Titan
Stoke Therapeutics CMO Barry Ticho Executes 5,545 Share Sales Under 10b5-1 Plan - Kalkine Media
Beta Bionics CMO Russell sells $80,676 in company stock By Investing.com - Investing.com South Africa